Article
Molecular characterization of ctDNA from Chinese patients with advanced gastric adenocarcinoma reveals actionable alterations for targeted and immune therapy.
Journal of molecular medicine (Berlin, Germany) - 1 Sept 2021
Zhang Meng, Qi Changsong, Wang Zhenghang, Chen Hui, Zhao Xiaochen, Zhang Xueming, Zhou Yifan, Gao Chan, Bai Yuezong, Jia Shuqin, Ji Jiafu
Abstract excerpt
Circulating tumor DNA (ctDNA) is considered an ideal sample type for genotyping patients with advanced unresectable cancer to inform treatment decision. It may better capture tumor heterogeneity, especially in gastric adenocarcinoma (GAC). However, there exists little evidence regarding genomic profiling of Chinese advanced GAC patients from ctDNA. Blood samples were obtained from 200 advanced GAC patients....
Topics
Join the communities discussing this publication.
